Altered Levels of Serum Adenosine Deaminase in Type 2 Diabetes Mellitus
Journal Title: National Journal of Laboratory Medicine - Year 2019, Vol 8, Issue 2
Abstract
ABSTRACT Introduction: Diabetes Mellitus (DM) is one of the leading not causes of increased morbidity and mortality in developing countries. Adenosine Deaminase (ADA) enzyme in purine metabolism catalyses the irreversible deamination of adenosine to inosine. Literature suggests that adenosine mimics the action of insulin and ADA reduces the adenosine levels, thus alters the intracellular glucose uptake. However, the role of ADA in Type 2 Diabetes Mellitus (T2DM) remains inconclusive. Aim: To measure serum ADA levels in T2DM patients and analyse its correlation with the glycaemic status. Materials and Methods: The case-control study included 54 clinically diagnosed T2DM subjects (aged 30-70 years) on oral hypoglycaemic treatment and 50 sex and age-matched apparently healthy individuals as controls. Serum Adenosine Deaminase (ADA), Fasting Blood Glucose (FBG), HbA1c, Lipid profile, {Total Cholesterol (TC), Triglyceride (TG), High Density Lipoprotein (HDL)} along with anthropometric indices for BMI were measured. Descriptive statistical analysis was done using unpaired Students’ t-test. Pearson correlation was used to analyse the correlation among various parameters. The p-value <0.05 was considered to be statistically significant. Results: In our study, FBG, HbA1c, ADA, TC, TG were significantly increased in T2DM subjects as compared to control group (p-value <0.0001), Triglyceride (p-value <0.001). In contrast, HDL-C levels were significantly reduced (p-value <0.0001) in T2DM subjects compared to control group. BMI of the T2DM subjects was significantly higher (p-value <0.01) than control. A positive correlation between ADA and HbA1c (r -value 0.64: p-value<0.0001), and ADA and FBS (r value 0.48: p-value <0.001) was observed. However, no correlation was found between ADA and BMI (r value 0.01: p-value 0.09). Conclusion: From the current study we propose that serum ADA can be used as a biomarker for predicting the glycaemic status of T2DM patient. It can also be used for assessment of dyslipidemia associated with diabetes.
Authors and Affiliations
P Vijayalakshmi, Supriya .
Keywords
Related Articles
- EP ID EP610034
- DOI 10.7860/NJLM/2019/41245:2353
- Views 118
- Downloads 0
Anaemia in Adult Nigerians in Ebonyi State, South Eastern Nigeria is not Related to Plasma Mineral Element Levels
Introduction: Anaemia remains one of the major public health challenges with global impacts, especially in developing countries. Causes of anaemia are multiple and variable among which are social, dietary, physiological...
A Study on the Biological Reference Interval of Vitamin D in North-East India
ABSTRACT Introduction: Vitamin D is the generic name given to all steroids that exhibit the biological activity of Cholecalciferol and derived from 7-dehydrocholesterol. Vitamin D has a major role in maintenance of healt...
Significance of Early Onset Peaks on High Performance Liquid Chromatography
Letter to Editor
A Review on Respiratory Infections in HIV-Infected People
ABSTRACT The infectious disease which created a huge impact on mankind over the past few decades is the Acquired Immunodeficiency Syndrome (AIDS). Although the devastating nature of this syndrome is not directly due to t...
A Clinico-histopathological Study of Appendageal Skin Tumours Over A Period of Four Years in A Tertiary Care Center
Introduction: Appendageal tumours arise from pilo sebaceous apparatus, eccrine and apocrine sweat glands. A great majority of these tumours are benign in nature. A clinicohistopathological co-relation is essential for a...